SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females

被引:0
|
作者
Li, Wei [1 ]
Liu, Wei [2 ]
Wang, Xiong [3 ]
Dou, Rui [1 ]
Zhu, Zunmin [1 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Inst Hematol, Henan Key Lab Stem Cell Differentiat & Modificat,P, Zhengzhou, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Publ Hlth, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China
关键词
Tuberculosis; Polymorphism; Susceptibility; Chinese females; DRUG-INDUCED HEPATOTOXICITY; RIFAMPIN CONCENTRATIONS; RISK;
D O I
10.1007/s10528-023-10392-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate the role of SLCO1B1 polymorphisms in pulmonary tuberculosis (PTB) risk among Chinese patients. This study comprised 600 PTB patients (mean age: 37.43 & PLUSMN; 12.73 years) and 600 healthy controls (mean age: 37.39 & PLUSMN; 12.57 years) from a Chinese population. The SLCO1B1 rs2306283 and rs4149056 polymorphisms were detected using TaqMan genotyping assay. Chi-square (& chi;(2)) test was applied to calculate the Hardy-Weinberg Equilibrium (HWE) among controls. Logistic regression analysis was used to examine the odds ratio (OR) and 95% confidence interval (CI). After adjustment for age and gender, the frequency of rs4149056-C was significantly higher in PTB group (P = 0.017, OR = 1.375, 95% CI 1.058-1.786); meanwhile, rs4149056 was associated with increased PTB risk in dominant model (P = 0.015, OR = 1.424, 95% CI 1.072-1.892). The frequency and genotype of rs2306283 showed no significant difference between the two groups. In stratified analysis, rs2306283-GG showed notable susceptibility to PTB (P = 0.027, OR = 1.563, 95% CI 1.051-2.323 in recessive model) in females; rs4149056-C was also significantly higher in female PTB group (P = 0.039, OR = 1.741, 95% CI 1.028-2.948). Neither of rs2306283 and rs4149056 polymorphisms was associated with PTB risk in males. A haplotype analysis showed that patients carrying at least one SLCO1B1*15 haplotype had higher PTB risk (P = 0.004, OR = 1.527, 95% CI 1.145-2.034). SLCO1B1 polymorphisms are associated with the susceptibility to pulmonary tuberculosis in Chinese females.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 50 条
  • [21] WITHDRAWN POLYMORPHISMS OF SLCO1B1, ENCODING MEMBRANE TRANSPORTER PROTEIN OATP1B1, ASSOCIATE WITH BLADDER CANCER SUSCEPTIBILITY
    Fujimoto, Naohiro
    Bui, Hoai
    Kubo, Tatsuhiko
    Tomisaki, Ikko
    Matsumoto, Tetsuro
    JOURNAL OF UROLOGY, 2014, 191 (04): : E428 - E428
  • [22] PharmVar GeneFocus: SLCO1B1
    Ramsey, Laura B.
    Gong, Li
    Lee, Seung-Been
    Wagner, Jonathan B.
    Zhou, Xujia
    Sangkuhl, Katrin
    Adams, Solomon M.
    Straka, Robert J.
    Empey, Philip E.
    Boone, Erin C.
    Klein, Teri E.
    Niemi, Mikko
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 782 - 793
  • [23] UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?
    Laura Alencastro de Azevedo
    Themis Reverbel da Silveira
    Clarissa Gutierrez Carvalho
    Simone Martins de Castro
    Roberto Giugliani
    Ursula Matte
    Pediatric Research, 2012, 72 : 169 - 173
  • [24] Influence of SLCO1B1 and SLCO2B1 Polymorphisms on Tacrolimus Pharmacokinetics and Clinical Efficacy and Safety.
    Alves, C.
    Felipe, C.
    Nishikawa, A.
    Salgado, P.
    Fajardo, C.
    Spinelli, G.
    Tedesco, H.
    Medina-Pestana, J.
    Hirata, M.
    Hirata, R.
    Rodrigues, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 503 - 503
  • [25] SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
    Rattanacheeworn, Punyabhorn
    Chamnanphon, Monpat
    Thongthip, Siriwan
    Kittanamongkolchai, Wonngarm
    Townamchai, Natavudh
    Avihingsanon, Yingyos
    Udomnilobol, Udomsak
    Prueksaritanont, Thomayant
    Jianmongkol, Suree
    Chariyavilaskul, Pajaree
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 521 - 530
  • [26] Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
    Song, Gonjin
    Chung, Jee-Eun
    Yee, Jeong
    Lee, Kyung-Eun
    Park, Kyungsoo
    Gwak, Hye-Sun
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
  • [27] The Role of SLCO1B1, ABCB1, and CHRNA1 Gene Polymorphisms on the Efficacy of Rocuronium in Chinese Patients
    Mei, Yang
    Wang, Sai-Ying
    Li, Yang
    Yi, Shuang-Qiang
    Wang, Chun-Yan
    Yang, Mi
    Duan, Kai-Ming
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (03): : 261 - 268
  • [28] SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
    Sortica, Vinicius A.
    Lindenau, Juliana D.
    Cunha, Maristela G.
    Ohnishi, Maria Deise O.
    Ventura, Ana Maria R.
    Ribeiro-dos-Santos, A. ndrea K. C.
    Santos, Sidney E. B.
    Guimaraes, Luciano S. P.
    Hutz, Mara H.
    PHARMACOGENOMICS, 2017, 18 (15) : 1401 - 1411
  • [29] ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population
    Bozina, Tamara
    Ganoci, Lana
    Karacic, Ena
    Simicevic, Livija
    Vrkic-Kirhmajer, Majda
    Klarica-Domjanovic, Iva
    Kriz, Tena
    Sertic, Zrinka
    Bozina, Nada
    ANNALS OF HUMAN BIOLOGY, 2022, 49 (7-8) : 323 - 331
  • [30] Influence of SLCO1B1 polymorphisms on atorvastatin efficacy and safety in Macedonian subjects
    Mladenovska, K.
    Grapci, A. Daka
    Vavlukis, M.
    Kapedanovska, A.
    Eftimovi, A.
    Geshkovska, N. Matevska
    Nebija, D.
    Dimovski, A. J.
    PHARMAZIE, 2017, 72 (05): : 288 - 295